New York governor Kathy Hochul unveiled plans for New York BioGenesis Park, a $430 million cell and gene therapy innovation hub in Nassau County, Long Island.
The state-of-the-art facility will catalyze CGT research, development, clinical manufacturing, and commercialization across New York, according to a press release from the governor's office. The state will make a $150 million investment — the largest nationwide for a cell and gene therapy hub.
New York BioGenesis Park is planned to be a full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization. When completed, the 700,000-square-foot park will create an end-to-end CGT innovation and supply center.
The project will be developed in multiple phases. The first phase will include the first cell and gene therapy tower and CDMO tower. The project has conditional commitments from two anchor tenants; one would operate the CDMO, the other would operate the incubator —a facility that will empower early-stage therapeutic developers by offering wet lab space, shared equipment, office space and other essential resources.
The CGT innovation hub is a critical component of the statewide CGT initiative announced in Governor Hochul's 2023 State of the State address.